Page last updated: 2024-08-24

aripiprazole and gamma-aminobutyric acid

aripiprazole has been researched along with gamma-aminobutyric acid in 4 studies

*gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system. [MeSH]

*gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system. [MeSH]

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Motomura, E; Nakagawa, M; Okada, M; Tanahashi, S; Yamamura, S1
De Berardis, D; Di Giannantonio, M; Martinotti, G; Moschetta, FS; Serroni, N1
Nawwar, DA; Sayed, RH; Zaki, HF1
Aboul-Fotouh, S; El-Salam, MFA; Elayat, WM; Elhossiny, RM; Habib, MZ; Hassan, GAM; Mohamad, MI; Zohny, SM1

Other Studies

4 other study(ies) available for aripiprazole and gamma-aminobutyric acid

ArticleYear
Dopamine D2 and serotonin 5-HT1A receptors mediate the actions of aripiprazole in mesocortical and mesoaccumbens transmission.
    Neuropharmacology, 2012, Volume: 62, Issue:2

    Topics: Animals; Antipsychotic Agents; Aripiprazole; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Male; Microdialysis; Nucleus Accumbens; Piperazines; Prefrontal Cortex; Quinolones; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Sulpiride; Synaptic Transmission; Ventral Tegmental Area

2012
Reversal of aripiprazole-induced tardive akathisia by addition of pregabalin.
    The Journal of neuropsychiatry and clinical neurosciences, 2013,Spring, Volume: 25, Issue:2

    Topics: Adult; Akathisia, Drug-Induced; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; gamma-Aminobutyric Acid; Humans; Piperazines; Pregabalin; Quinolones

2013
Role of the NRG1/ErbB4 and PI3K/AKT/mTOR signaling pathways in the anti-psychotic effects of aripiprazole and sertindole in ketamine-induced schizophrenia-like behaviors in rats.
    Inflammopharmacology, 2022, Volume: 30, Issue:5

    Topics: Animals; Antipsychotic Agents; Aripiprazole; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Glutamates; Humans; Imidazoles; Indoles; Ketamine; Male; Neuregulin-1; Parvalbumins; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Receptor, ErbB-4; RNA, Messenger; Schizophrenia; Signal Transduction; Sucrose; TOR Serine-Threonine Kinases

2022
Memantine/Aripiprazole Combination Alleviates Cognitive Dysfunction in Valproic Acid Rat Model of Autism: Hippocampal CREB/BDNF Signaling and Glutamate Homeostasis.
    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2023, Volume: 20, Issue:2

    Topics: Animals; Aripiprazole; Autism Spectrum Disorder; Autistic Disorder; Brain-Derived Neurotrophic Factor; Cognitive Dysfunction; Disease Models, Animal; Female; gamma-Aminobutyric Acid; Glutamates; Hippocampus; Homeostasis; Male; Memantine; Pregnancy; Rats; Rats, Wistar; Valproic Acid

2023